Iantrek
NY - White PlainsMedical Devices
Focus: Iantrek develops micro-interventional surgical devices for glaucoma treatment, with a focus on minimally invasive approaches to intraocular pressure management. The company is a Series C+ stage medical device innovator operating in the specialized ophthalmology market.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
SERIES C +
Open Jobs
0
About Iantrek
AI assessmentNot HiringNo open roles listed right now. Follow Iantrek to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
C-Rex Instrument
Primary Open Angle Glaucoma (POAG)Clinical Trials (1)
NCT06615661A Real-World Evidence Study of Goniotomy With the C-REX™ Instrument in Patients With Primary Open Angle Glaucoma
N/AHelp build intelligence for Iantrek
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.